The U.S.-based firm provides clinical development services to biopharmaceutical, medical device and consumer health companies around the globe.
“With the new round of financing, we will further enhance our innovative service offering and continue business expansion by organic growth and M&A in order to better serve our clients worldwide,” Ling Zhen, global chair and CEO of ClinChoice, said in a news release from the company.
Other investors include Lilly Asia Ventures and Goldman Sachs.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.